yongfu Zhu

Dr. yongfu Zhu


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Pharmacological Research
Verified
Journal Article
Closed access
FZFeinan Zhou
Feinan Zhou
JMJia Ma
Jia Ma
YZyongfu Zhu
yongfu Zhu
Tianming WangTianming Wang
Tianming Wang
YYYue Yang
Yue Yang
JZJian-Ye Zhang
Jian-Ye Zhang

21 October 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
YZyongfu Zhu
yongfu Zhu
PZPengcheng Zhang
Pengcheng Zhang
XHXingxing Huo
Xingxing Huo
YLYi Ling
Yi Ling
XLXiang Lv
Xiang Lv
HSHang Song
Hang Song
The apelin receptor (APJ) is a key player in tumour angiogenesis, but its role in hepatocellular carcinoma (HCC) remains unclear. This study aims to elucidate the function of the apelin/APJ pathway in HCC using a multi‐omics approach and identify potential therapeutic biomarkers. Differentially expressed genes related to the apelin/APJ axis were identified from bulk transcriptomics to reveal HCC‐associated disparities. Single‐cell and spatial transcriptomics were used to localize and analyse the function of these genes. Machine learning models were constructed to predict outcomes based on apelin/APJ expression, and experimental validation was conducted to explore the pathway's impact on HCC angiogenesis. Single cell analysis revealed an overexpression of APJ/Aplin in the endothelium. The stemness of endothelial cell (EC) with high apelin/APJ was enhanced, as well as the expression of TGFb, oxidative stresses and PI3K/AKT pathway genes. Spatial transcriptomics confirmed that EC populations with high APJ scores were enriched within the tumour. Machine learning models showed high prognostic accuracy. High APJ expression was linked to worse outcomes (p = 0.001), and AUC values were high (1 year, 3 year, 5 year) (0.95, 0.97, 0.98). Immune suppression and non‐responsiveness of immune therapy were also seen in high‐risk groups. The experimental validation showed that silencing apelin reduced angiogenesis (p < 0.05), endothelial proliferation, decreased expression of ANG2, KLF2, VEGFA and lower ERK1/2 phosphorylation. Apelin may serve as a potential therapeutic target in HCC, given its role in promoting tumour angiogenesis and poor patient outcomes.

20 September 2024 in Oncologie
Verified
Journal Article
Open access
PDF file
SBSu Bu
Su Bu
TYTing Ye
Ting Ye
HGHang Gao
Hang Gao
HSHang Song
Hang Song
YZyongfu Zhu
yongfu Zhu
Along with the continuous development of chromatin immunoprecipitation sequencing and its derivative technologies, as well as an increased understanding of epigenetic modification, the post-translational modification of histones has gradually been revealed, including their acetylation, methylation, phosphorylation, and ubiquitination, and their roles in diseases, especially cancer, have also been gradually explored. The role and regulation of histone methylation and acetylation in cancer and the mechanism of action of drugs have been thoroughly discussed. In particular, the review highlights recent advances in the development of epigenetic-targeted therapies and the challenges that remain in translating these findings into clinical applications. Research on epigenetic-targeted drugs is in its infancy, and more research in the fields of dominant biology, structural biology, and pharmacodynamics is needed. Through this review, the authors aim to provide theoretical guidance for the construction and clinical transformation of histone methylation and acetylation.

1 April 2023 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
GWGao-Xiang Wang
Gao-Xiang Wang
JZJie Zhou
Jie Zhou
YCYou-Mou Chen
You-Mou Chen
LXLiang-Dong Xu
Liang-Dong Xu
STShan-Ming Tao
Shan-Ming Tao
MXMingran Xie
Mingran Xie
Background: Acupuncture has achieved good results in the treatment of cough, asthma, chronic obstructive pulmonary disease (COPD) and other lung diseases, but the mechanism associated with acupuncture in the treatment of chronic cough induced by lung surgery is unknown. We investigated whether acupuncture therapy could improve the symptoms of chronic cough after lung surgery through cyclic-AMp dependent protein kinase A (PKA)/cyclic-AMp dependent protein kinase C (PKC) regulation of the transient receptor potential vanilloid-1 (TRPV1) signaling pathway. Methods: The guinea pigs were divided into 5 groups: the Sham operation Group (Sham), the Model Group (Model), the Electroacupuncture + Model Group (EA + M), the H89 + Model Group (H89 + M) and the Go6983 + Model Group (Go6983 + M). The effect of treatment was determined by measuring cough symptoms (number of coughs/cough incubation period) as the outcome criterion. The levels of inflammatory cytokines in bronchoalveolar lavage fluid (BALF) and blood were determined by enzyme-linked immunosorbent assays (ELISA). Lung tissue was stained with hematoxylin and eosin (H&E). The expression of p-PKA, p-PKC and p-TRPV1 proteins was measured by Western blotting. The mRNA levels of TRPV1, Substance P (SP), calcitonin gene-related peptide (CGRP) and neurokinin-1R (NK1R) were measured by real-time polymerase chain reaction (RT-PCR). Results: Acupuncture significantly reduced the cough frequency and prolonged the cough latency of chronic cough in guinea pigs after lung surgery. In addition, acupuncture reduced the damage to lung tissue. The levels of inflammatory cytokines decreased in all treatment groups, the expression levels of p-PKA, p-PKC and p-TRPV1 were significantly inhibited and the mRNA levels of TRPV1, SP, CGRP and NK1R decreased significantly after acupuncture treatment. Conclusions: Acupuncture therapy ameliorated chronic cough in guinea pigs after lung surgery by regulating the TRPV1 signaling pathway via PKA/PKC. Our results showed that acupuncture may be an effective treatment of chronic cough after lung surgery, and also clarified the potential mechanism, which provides a theoretical basis for the clinical treatment of patients with chronic cough after lung surgery.

1 January 2005 in MATERIALS TRANSACTIONS
Verified
Journal Article
Open access
SHSang-Hwui Hong
Sang-Hwui Hong
KMKouji Mimura
Kouji Mimura
YZyongfu Zhu
yongfu Zhu
MIMinoru Isshiki
Minoru Isshiki

25 November 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
XHXing-Xing Huo
Xing-Xing Huo
SWShu-Jie Wang
Shu-Jie Wang
HSHang Song
Hang Song
MLMing-De Li
Ming-De Li
HYHua Yu
Hua Yu
JZJian-Ye Zhang
Jian-Ye Zhang
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer malignancy worldwide and is known to have poor prognosis. The pathogenesis behind the development of HNSCC is not fully understood. Modifications on RNA are involved in many pathophysiological processes, such as tumor development and inflammation. Adenosine-related RNA modifications have shown to be linked to cancer and may play a role in cancer occurrence and development. To date, there are at least 170 different chemical RNA modifications that modify coding and non-coding RNAs (ncRNAs). These modifications affect RNA stability and transcription efficiency. In this review, we focus on the current understanding of the four major RNA adenosine modifications (N6-Methyladenosine, N1-Methyladenosine, Alternative Polyadenylation Modification and A-to-I RNA editing) and their potential molecular mechanisms related to HNSCC development and progression. We also touch on how these RNA modifications affect treatment of HNSCCs.